Ophthalmology · Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids)

Which prostaglandin analogue has a dual mechanism of action — both FP receptor agonism and EP2/EP3 receptor activity — and is available as a preservative-free formulation?

  • A Latanoprostene bunod
  • B Latanoprost
  • C Bimatoprost
  • D Tafluprost
Correct answer: A. Latanoprostene bunod

Explanation

Latanoprostene bunod (Vyzulta) is a nitric oxide-donating prostaglandin analogue — it is cleaved in the eye to latanoprost acid (FP receptor agonist increasing uveoscleral outflow) and butanediol mononitrate (releases NO, which activates soluble guanylate cyclase, increasing trabecular outflow via the NO-cGMP pathway). This dual mechanism targets both uveoscleral and trabecular outflow pathways. Tafluprost is a preservative-free prostaglandin but works solely via FP receptors. Bimatoprost is a prostamide.

Reference: Khurana Comprehensive Ophthalmology, 7th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids) MCQs

See all Ocular Pharmacology and Therapeutics (Anti-VEGF, Anti-glaucoma Classes, Steroids) MCQs →